Calithera Biosciences, Inc.
Arginase inhibitor combination therapies

Abstract:

The disclosure relates to methods of treating or preventing a disease in a subject by conjointly administering to the subject an arginase inhibitor disclosed herein and a composition comprising immune cells disclosed herein.